Germany· DE-A57-74bc0f4db09db496
Driponin
A ivermectin product containing ivermectin, registered in Germany by Pädia Gmbh, De, Heppenheim. The same ATC class is registered in 15 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Ivermectin is registered in 15 of 19 countries.
Countries holding a registration under ATC P02CF01 (ivermectin), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 8 of them publish a price we can compare per daily dose
Ivermectin · ATC P02CF01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Ivermectin
- Manufacturer
- Pädia Gmbh, De, Heppenheim
- Country
- Germany (DE)
- ATC code
- P02CF01
- ATC class
- Ivermectin
- Defined daily dose
- 12 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
111 interactions on record for ivermectin.
Graded by severity as the source publishes them — 84 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ivermectin · interactions on record
111 records
- 84 moderate
- 2 minor
- 25 info
Most severe, free to view
- AprepitantA04AD12moderate
- LonafarnibA16AX20moderate
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ivermectin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBldaxn Ivermectin Lotion0.5%GUANGZHOU YUSONG FINE CHEMICLS Co., Ltd
- FinlandAnimec vetChanelle Pharmaceuticals Manufacturing Limited
- CzechiaIVERMEKTIN ARISTOAristo Pharma GmbH, Berlin
- PolandIvermectin Medical ValleyMedical Valley Invest AB
- NetherlandsIvergalen 3 mg, tablettenGalenicum Derma S.L.U.
- CanadaBIMECTINBIMEDA-MTC ANIMAL HEALTH INC
- FranceIVERMECTINE ARROW LAB 3 mg, compriméARROW GENERIQUES
- SwedenCesora 10 mg/g KrämLaboratoires Medgen
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Ivergelan, Ivermectin Stada
- Belgium · Cesora, Ivermectin Eg
- Bulgaria · Ивермектин, Скабал
- Cyprus · Scaball, Soolantra
- Czechia · Ivermektin Aristo, Loutol
- Denmark · Ivermectin Medical Valley, Ivermectin Newbury
- Estonia · Ivermectin Orion, Soolantra
- Spain · Ivercare, Ivergalen
- Finland · Ivermectin Glenmark, Ivermectin Medical Valley
- France · Bibovel, Cesora
- United Kingdom (Northern Ireland) · Ivermectin, Ivermectin Aristo
- Greece · Scaball, Soolantra
- Hungary · Soolantra
- Ireland · Iverscab, Soolantra
- Iceland · Ivermcetin Stada, Ivermectin Medical Valley
- Italy · Efacti, Ivercare
- Lithuania · Ivermectin Orion, Soolantra
- Luxembourg · Ivermectin Eg, Ivermectin Substipharm
- Latvia · Ivermectin Orion, Ivermectine Orion
- Malta · Soolantra
- Netherlands · Ivergalen, Ivermectin Substipharm
- Norway · Ivermectin Glenmark, Ivermectin Medical Valley
- Poland · Ivermectin Medical Valley, Ivermectin Orion
- Portugal · Ivergalen, Ivermectina Cantabria
- Romania · Soolantra
- Sweden · Cesora, Efrinter
- Slovakia · Ivermectin Exeltis, Soolantra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0bef86e6-ccd1-42b6-ac91-effca5edf29b GET /v1/drugs/0bef86e6-ccd1-42b6-ac91-effca5edf29b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Ivermectin",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about ivermectin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.